Gynecologic Cancers Expert at Newyork-Presbyterian Is Available to Discuss HPV Vaccination and Cancer Prevention
New York-Presbyterian Hospital
Dr. Richard Liebowitz has been appointed president of NewYork-Presbyterian Brooklyn Methodist Hospital, effective February 6.
Leading breast cancer experts from NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine will be presenting at the San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas from December 6, 2016 through December 10, 2016.
NewYork-Presbyterian and New York Methodist Hospital have established a new relationship aimed at improving access and enhancing care for patients in Brooklyn.
A newer generation left ventricular assist device (LVAD) provides better outcomes for patients with advanced heart failure at six months compared to its predecessor, according to a new study. Researchers presented data from the MOMENTUM 3 trial at the 2016 Scientific Sessions of the American Heart Association and also co-published in the New England Journal of Medicine.
NewYork-Presbyterian has launched NYP Ventures, a strategic investment fund that supports innovative digital healthcare companies.
NewYork-Presbyterian has launched Digital Urgent Care and Virtual Visit, two new online services connecting patients with NYP providers, which includes ColumbiaDoctors, Weill Cornell Medicine’s Physician Organization and NewYork-Presbyterian Medical Groups, through real-time video. The services are available on www.nyp.org and through the NYP mobile app (mobileapp.nyp.org). Digital Urgent Care and Virtual Visit are the latest offerings from NYP OnDemand, a comprehensive suite of digital health services designed to improve and expand patient care.
NewYork-Presbyterian/Westchester has received the 2016 Planetree Distinction Award for Leadership and Innovation in Patient-Centered Care.
A new study has found that the rate of prostate biopsies and radical prostatectomies decreased following a 2012 United States Preventative Task Force (USPSTF) recommendation against prostate specific antigen (PSA) testing.
Dr. Charles G. Drake has joined NewYork-Presbyterian/Columbia University Medical Center (CUMC) as director of genitourinary oncology and associate director for clinical research at the Herbert Irving Comprehensive Cancer Center, effective October 1.
An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective capture of embolic debris and does not change neurocognitive function for transcatheter aortic valve replacement (TAVR) patients.
Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing percutaneous coronary intervention to treat coronary artery disease, according to results from the ILLUMIEN III: OPTIMIZE PCI trial.
Physicians and scientists from NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine will attend the 2016 63rd Annual American Academy of Child Adolescent Psychiatry (AACAP) Meeting from October 24-29.
Dr. Zoltan Antal has been named chief of pediatric endocrinology at the Phyllis and David Komansky Center for Children’s Health at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective Aug. 1.
NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Medical Center and the FDNY, is launching the Mobile Stroke Treatment Unit (MSTU), the first of its kind on the East Coast.
A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers, NewYork-Presbyterian and Weill Cornell Medicine researchers find in a new clinical study. The results are published in the Annals of Surgical Oncology.
The Center for Acute Respiratory Failure and Cardiac ECMO Program at NewYork-Presbyterian/Columbia University Irving Medical Center and the Pediatric ECMO Program at NewYork-Presbyterian/Morgan Stanley Children’s Hospital have been designated a Platinum Level Center of Excellence for the Excellence in Life Support Award from the Extracorporeal Life Support Organization (ELSO, an international non-profit consortium dedicated to the development of novel therapies for people with organ failure).
HeartSmarts, a faith-based community education and outreach program, is an effective method for teaching underserved communities about heart health in New York City, according to a study published in the Journal of Religion and Health.
NewYork-Presbyterian/Columbia University Medical Center has been named a Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence, the first of its kind in New York. The designation, made by Cure HHT, recognizes institutions that provide outstanding specialized care for HHT, a rare genetic disorder that can cause sudden, catastrophic internal bleeding and stroke.
Fifteen years ago, New York City was changed forever when terrorists struck down the Twin Towers of the World Trade Center. Almost 3,000 people lost their lives in the attacks and more than 6,000 people were injured. The tragedy of that day brought all of New York City together: the first responders, paramedics, firefighters, police officers, doctors, nurses, area businesses, co-workers, neighbors and strangers. NewYork-Presbyterian staff was called into action to help victims in the immediate aftermath of the attack, with four NYP EMS professionals sacrificing their lives that day to save others.Several NewYork-Presbyterian staff members came together to share their stories throughout the week.
NewYork-Presbyterian, one of the largest and most comprehensive hospitals in the nation, is ranked New York’s No. 1 hospital for the 16th consecutive year, and No. 6 in the United States, according to the U.S. News and World Report annual survey of “Best Hospitals,” published online today.
NewYork-Presbyterian has announced the rollout of NYP OnDemand, a new suite of digital health services designed to improve and expand patient care, while also extending access to the clinical expertise of NewYork-Presbyterian’s physicians to their peers throughout the Hospital’s vast healthcare network.
Joe Ienuso has been named NewYork-Presbyterian’s group senior vice president of facilities and real estate, effective August 1.
Food Allergy Research & Education (FARE), the leading nonprofit organization working on behalf of the 15 million Americans with food allergies, today announced the expansion of the FARE Clinical Network, which now comprises 28 centers of excellence across the country. The FARE Clinical Network, dedicated to changing the face of food allergy care, is the only collaborative network of its kind.
NewYork-Presbyterian has received two grants totaling more than $3.75 million from the New York State Department of Health AIDS Institute for its continued efforts to prevent HIV/AIDS in at-risk youth.
The Centers for Medicare & Medicaid Services (CMS) today announced that it has selected NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine to participate in a care delivery model that supports and encourages higher quality, more coordinated cancer care.
Dr. James Gallagher, director of the William Randolph Hearst Burn Center at NewYork-Presbyterian/Weill Cornell Medical Center recommends the following safety tips to avoid burns from barbecues, fireworks and other popular summer activities:
NewYork-Presbyterian Hospital has been certified by The Joint Commission and the American Heart Association/American Stroke Association as a Comprehensive Stroke Center (CSC), the highest level of stroke certification a hospital can receive. They join the elite group of certified Comprehensive Stroke Centers throughout the United States.
For 10 years running, NewYork-Presbyterian Hospital ranks in more pediatric specialties than any other New York metro area hospital in U.S. News & World Report’s “Best Children’s Hospitals.”
NewYork-Presbyterian announced the winners of the InnovateNYP Pediatric App Challenge during Demo Day on June 9, an event marking the completion of a 10-week long competition in which designers, developers, clinicians and startups worked to create tech advancements in pediatric healthcare.
Dr. David E. Cohen, an internationally renowned physician-scientist who combines clinical care as a hepatologist with research focused on obesity-related liver disease, has been named chief of the Division of Gastroenterology and Hepatology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.
CIO Magazine has named NewYork-Presbyterian a 2016 CIO 100 Award winner. The 29th annual awards program honors and recognizes the cutting-edge innovations of companies that demonstrate excellence and achievement in information technology.
More than 280 physicians affiliated with NewYork-Presbyterian have been recognized as among the best doctors in the New York metropolitan region in this year’s edition of New York Magazine’s “Best Doctors” issue.
Dr. Craig Albanese has been appointed senior vice president and chief operating officer at NewYork-Presbyterian/Morgan Stanley Children’s Hospital and Sloane Hospital for Women, effective June 6.
Dr. Maria A. Oquendo was inducted in as American Psychiatric Association’s (APA) newest president at the organization’s annual meeting in Atlanta.
Physicians and leaders from NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine will attend the 2016 American Psychiatric Association (APA) annual meeting in Atlanta, Georgia from May 14-18.
Researchers from NewYork-Presbyterian/Columbia University Medical Center (CUMC) have found that incorporating psychiatrists and social workers into the medical team for hospitalized patients dramatically reduced length of stay (LOS) and costs.
In a paper published in this month's Journal of Clinical Investigation, researchers at the Weill Medical College of Cornell University reported that mice that were administered a gene-based therapeutic agent showed marked acceleration of the onset of new hair growth two weeks after treatment.
A painless, 20-second test could save more than 100,000 lives annually in the United States by detecting lung cancer at an early, curable stage, say researchers. Their findings, published in the July 10th issue of The Lancet, show that low-dose CT (low-radiation-dose computed tomography) can find lung tumors long before they appear on traditional chest x-rays.
A new treatment protocol of Interleukin II (IL-2) is currently under development as an immune stimulant for HIV-positive individuals who have responded to medication but have not achieved recovery of their immune system.
Researchers at Weill Medical College of Cornell University and New York Presbyterian Hospital have successfully used a new technique to identify the genetic mutation that causes sickle cell anemia, As a result, healthy twins were born to parents who both carry the mutation.